Development of a noninvasive HIFU treatment for breast adenocarcinomas using a toroidal transducer based on preliminary attenuation measurements.
Adenocarcinoma
Attenuation
Breast
HIFU
Tumor
Ultrasound
Journal
Ultrasonics
ISSN: 1874-9968
Titre abrégé: Ultrasonics
Pays: Netherlands
ID NLM: 0050452
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
21
07
2020
revised:
21
01
2021
accepted:
04
05
2021
pubmed:
15
5
2021
medline:
29
6
2021
entrez:
14
5
2021
Statut:
ppublish
Résumé
Breast cancer is the most commonly diagnosed type of cancer among women. For the last fifteen years, treatments that are less invasive than lumpectomy, such as high-intensity focused ultrasound (HIFU) therapy, have been developed, with encouraging results. In this study, a toroidal HIFU transducer was used to create lesions of at least 2 cm in diameter within less than one minute of treatment. The toroidal HIFU transducer created two focal zones that led to large, fast and homogeneous ablations (10.5 cc/min). The experiments were conducted in 30 human samples of normal breast tissues recovered from mastectomies to measure acoustic attenuation (N = 30), and then, HIFU lesions were created (N = 15). Eight HIFU ablations were performed to evaluate the reproducibility of the lesions. HIFU lesions were created in 45 s with a toroidal HIFU transducer working at 2.5 MHz. The longest and shortest axes of the HIFU lesions were 21.7 ± 3.1 mm and 23.5 ± 3.3 mm respectively, corresponding to an average volume of 7.3 ± 1.4 cm
Identifiants
pubmed: 33990009
pii: S0041-624X(21)00093-7
doi: 10.1016/j.ultras.2021.106459
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106459Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.